This AASLD 2018 Hepatitis B Guidance is intended to complement the AASLD 2016 Practice
Guidelines for Treatment of Chronic Hepatitis B (1) and update the previous hepatitis B …

Hepatitis B virus (HBV) is a significant global pathogen, infecting more than 240 million
people worldwide. While treatment for HBV has improved, HBV patients often require lifelong …

Representatives from academia, industry, regulatory agencies, and patient groups convened
in March 2019 with the primary goal of developing agreement on chronic hepatitis B virus (…

… The incidence of renal and bone events for up to 7 years of treatment was low in a recent
study, with 1.7% showing elevated serum creatinine and no significant change in bone mineral …

The virological and immunological features of hepatitis C virus (HCV) infection were studied
weekly for 6 months after accidental needlestick exposure in five health care workers, four of …

We investigated type 2 diabetes (T2D) genetic susceptibility via multi-ancestry meta-analysis
of 228,499 cases and 1,178,783 controls in the Million Veteran Program (MVP), DIAMANTE…

The mammalian intestinal tract is colonized by trillions of beneficial commensal bacteria that
are anatomically restricted to specific niches. However, the mechanisms that regulate …

We report a genome-wide association study (GWAS) of coronary artery disease (CAD)
incorporating nearly a quarter of a million cases, in which existing studies are integrated with data …

The Million Veteran Program (MVP) was established in 2011 as a national research initiative
to determine how genetic variation influences the health of US military veterans. Here we …

Hepatitis C virus (HCV) has a high propensity for persistence. To better define the immunologic
determinants of HCV clearance and persistence, we examined the circulating HCV-…